Follow-The-Filings

Security · featured owners

TNGX

Tango Therapeutics Inc. COM Equity as of 2026 Q2 among managers we track

  • 2 Owners
  • Max 1.8%
  • $384M
  • 1 new 1 add

Who owns this now

Largest portfolio weights among featured holders · max 1.8% (Farallon Capital Management) · not free-float ownership

  1. Farallon Capital Management add 1.8%

holders

sorted by % of portfolio · long equity only · open a manager for their book

history
Farallon Capital Management 2026 Q2 1.8% Add +35.0% 12,277,000 $384M hist
Ron Baron - Bamco Inc. /NY/ (Baron Capital) 2026 Q2 0% New 0.0% 15,000 $469K hist

2 current · options excluded

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $36.53M $42.07M $62.38M
Gross profit — — —
Gross margin — — —
Net income -$101.74M -$130.3M -$101.59M
Net margin * -278.5% -309.7% -162.9%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $346.54M $266.34M $353.76M
Total non-current assets * $56.03M $50.15M $44.93M
Total assets $402.57M $316.49M $398.69M
Total current liabilities $45.94M $38.17M $21.68M
Total non-current liabilities * $103.52M $78.8M $30.83M
Total equity $253.11M $199.52M $346.18M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$117.98M -$131.5M -$138.89M
Cash from investing $41.43M $86.13M -$40.86M
Cash from financing $82.41M $47.66M $222.5M
Net change in cash $5.85M $2.29M $42.75M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders